HNF1B rs4430796: Understanding Your Genetic Association
The rs4430796 variant is a common genetic marker located within the HNF1B gene on chromosome 17. Research has identified this variant as a susceptibility locus associated with varying risks for prostate cancer, endometrial cancer, and type 2 diabetes.
What each genotype means
Elevated prostate cancer risk
You carry two copies of the A allele at rs4430796 in the HNF1B locus, which has been consistently associated in genome-wide association studies with a modestly increased statistical risk of prostate cancer. Interestingly, research indicates an inverse association where this allele correlates with a slightly lower risk of type 2 diabetes. Because this variant represents a complex non-coding susceptibility factor with modest effect size, it does not diagnose any disease or dictate clinical management.
Carried by roughly 20% to 25% of individuals in European and East Asian populations, and slightly less common in African populations.
Intermediate risk profile
You carry one copy of the A allele and one copy of the G allele at rs4430796. Population studies indicate that heterozygous individuals exhibit an intermediate relative risk for prostate cancer and type 2 diabetes compared to homozygous genotypes. This variant exerts only a subtle regulatory effect on HNF1B expression and contributes minimally to overall polygenic risk.
Carried by approximately 45% to 50% of individuals across European populations and is widely observed globally.
Typical risk profile
You carry two copies of the G allele at rs4430796, which is associated with baseline or modestly decreased statistical odds of developing prostate cancer relative to A-allele carriers. However, some studies note that the G allele exhibits a slight positive association with risk for type 2 diabetes and certain other traits. Overall lifestyle, family history, and routine preventive care remain far more informative than this single marker.
Carried by roughly 25% to 30% of individuals of European ancestry and is common across worldwide ancestries.
What is rs4430796?
The identifier rs4430796 refers to a specific single nucleotide polymorphism (SNP) located on chromosome 17q12. This region is home to the HNF1B gene, which plays a critical role in the development of various organs, including the pancreas, kidneys, and reproductive tract. In the context of genomics, rs4430796 is a non-coding variant, meaning it does not directly alter the protein sequence produced by the gene. Instead, it is thought to influence how the HNF1B gene is regulated or expressed. Because this SNP is frequently studied in large-scale genome-wide association studies (GWAS), it has become a well-documented marker for researchers investigating the genetic architecture of complex diseases. It is important to note that while this variant is statistically associated with certain health conditions, it is only one of many factors—including other genetic markers, lifestyle, and environmental influences—that contribute to an individual's overall health profile.
The Role of the HNF1B Gene
The HNF1B gene, formerly known as TCF2, encodes a transcription factor called hepatocyte nuclear factor-1 beta. Transcription factors are proteins that bind to specific DNA sequences to control the rate at which genes are turned on or off. HNF1B is essential for the proper development and function of several tissues, particularly in the embryonic stages. It is highly active in the development of the kidneys, the pancreas, and the genital tract. Mutations in the coding regions of this gene are known to cause rare, severe conditions such as maturity-onset diabetes of the young (MODY) and renal cysts and diabetes syndrome. The rs4430796 variant, however, is located in a non-coding region near the gene. Researchers study this variant to understand how subtle variations in gene regulation might contribute to more common, complex conditions like prostate cancer or metabolic changes related to type 2 diabetes.
Research Associations and Evidence Strength
The association between rs4430796 and disease risk has been the subject of numerous large-scale studies. Research consistently shows that this variant is linked to prostate cancer risk, with some alleles showing a protective effect while others are associated with higher susceptibility. Interestingly, the same variant has been observed to have an inverse relationship with type 2 diabetes, meaning the allele that may increase risk for one condition might be associated with a lower risk for the other. Additionally, studies have identified a link between this locus and endometrial cancer. While the statistical evidence for these associations is strong in large populations, the clinical utility of this information remains limited. The effect sizes for these associations are generally modest, and the variant does not act as a diagnostic tool. Current research continues to explore the biological mechanisms behind these links, as the exact way this non-coding variant influences disease risk is still being investigated.
What You Can and Cannot Do With This Information
Understanding your genotype for rs4430796 provides insight into your genetic predisposition as identified by current scientific research, but it should not be used to make medical decisions. Because this variant is associated with complex, multifactorial conditions, it cannot predict whether an individual will develop a disease. Genetic associations are statistical observations across large groups of people and do not translate directly to individual health outcomes. If you are concerned about your risk for prostate cancer, endometrial cancer, or type 2 diabetes, the most effective approach is to consult with a healthcare professional. They can evaluate your personal and family medical history, lifestyle factors, and clinical screenings to provide personalized guidance. Do not use genetic data to alter your diet, medication, or screening schedule without first discussing these results with a qualified clinician who can interpret them within the context of your overall health.
How common is this variant?
The rs4430796 variant is common across global populations, with the minor allele frequency in European populations typically ranging between 0.45 and 0.49.
Frequently asked questions
Is rs4430796 a diagnostic test for prostate cancer?
No, rs4430796 is not a diagnostic test. It is a genetic marker associated with a statistical change in risk, but it cannot determine if you have or will develop prostate cancer.
Does having the 'risk' allele mean I will get diabetes?
No. Genetic associations are based on population averages and do not guarantee health outcomes. Many people with the associated allele never develop diabetes, and many without it do.
Can I change my genotype for rs4430796?
No, your genotype is determined at conception and remains the same throughout your life. You cannot change your DNA sequence.
Should I share my rs4430796 results with my doctor?
You can share any health information with your doctor, but they may not find this specific SNP useful for clinical management. Focus on discussing your family history and standard health screenings.
Sources & further reading
Educational information only, last refreshed 10/19/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4430796?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29